Combo Product Office To Tackle Intercenter Agreements, “Chemical Action”
FDA's final rule defining primary mode of action will be released within the next six months, Office of Combination Products Director Mark Kramer projected Jan. 11-12
FDA's final rule defining primary mode of action will be released within the next six months, Office of Combination Products Director Mark Kramer projected Jan. 11-12